Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
33 hedge funds and large institutions have $4.29M invested in Albireo Pharma Inc in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 11 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
13% less funds holding
Funds holding: 38 → 33 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
67% less call options, than puts
Call options by funds: $5K | Put options by funds: $15K
72% less capital invested
Capital invested by funds: $15.3M → $4.29M (-$11M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$818K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$171K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$31.4K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$19.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.18M |
| 2 |
AIC
AWM Investment Company
New York
|
-$1.94M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$1.76M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.46M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.12M |
ALBO Hedge Fund Activity: Q4 2015 in Review
33 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q4 2015, worth a combined $4.29M — down 72% from $15.3M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ALBO and 6 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 8 added.
The largest buyer was Renaissance Technologies, adding an estimated $818K. The largest seller was Wellington Management Group, exiting entirely with an estimated $3.18M sold.
- 33 institutional investors held Albireo Pharma Inc (ALBO) as of Q4 2015, down from 38 in Q3 2015.
- Funds reported $4.29M of Albireo Pharma Inc stock for Q4 2015, down 72% quarter-over-quarter.
- 6 funds opened new Albireo Pharma Inc positions in Q4 2015 and 11 closed out, a net change of -5 holders.
- The largest Albireo Pharma Inc buyer in Q4 2015 was Renaissance Technologies, an estimated $818K added.
- The largest Albireo Pharma Inc seller in Q4 2015 was Wellington Management Group, an estimated $3.18M sold.
Based on aggregated 13F filings for Q4 2015.